Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

TMOTMO
Showing 8 of 31 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in Thermo Fisher Scientific Inc.

Yes. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS holds 2,472,524 shares of TMO (Thermo Fisher Scientific), worth $1.2B, as of its Q2 2026 13F filing. It increased the position by 22,827 shares (+0.9%) from Q1 2026. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS has held TMO in every 13F on record since Q4 2018, 31 quarterly filings. TMO is 0.2% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS' reported 13F portfolio.

Current Value

$1.2B

Current Shares

2.5M

Total Value Change

-$98.6M

Total Shares Change

+309,037

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+0.9%
$1.2B0.2%$500.98
38
2026-Q1
Increased
2.4M
+0.9%
$1.2B0.3%$490.66
38
2025-Q4
Increased
2.4M
+0.6%
$1.4B0.3%$577.86
38
2025-Q3
Decreased
2.4M
-21.4%
$1.2B0.3%$483.32
0
2025-Q2
Increased
3.1M
+11.7%
$1.2B0.3%$403.68
43
2025-Q1
Increased
2.8M
+13.6%
$1.4B0.4%$494.90
43
2024-Q4
Increased
2.4M
+11.9%
$1.3B0.3%$516.97
43
2024-Q3
Increased
2.2M
+0.9%
$1.3B0.3%$614.24
38

Other major holders of TMO: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used